
Hubble Therapeutics
Developer of a gene therapy platform designed for a rare genetic eye disorder that typically presents with severe progressive visual impairment. The company's proprietary gene therapy treats leber con...
Valuation
$0
Share Price
N/A
Total Raised
$20.3M
Last Round
N/A